» Articles » PMID: 9612349

Mouse and Rat Plasma Renin Concentration and Gene Expression in (mRen2)27 Transgenic Rats

Overview
Journal Am J Physiol
Specialty Physiology
Date 1998 Jun 5
PMID 9612349
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The (mRen2)27 transgenic rat [TGR(mRen2)27] is said to have low plasma levels of active renin. We used a direct radioimmunoassay (RIA) for mouse submaxillary renin, as well as an indirect enzyme-kinetic assay based on the generation of angiotensin I with modification of the pH optimum, to measure rat and mouse plasma renin activity (PRA), plasma renin concentration (PRC), and plasma prorenin in TGR before and after lisinopril. The relationship between rat PRC and % rat kidney extract was steepest at pH 6.0 and flat at pH 8.5, whereas the relationship between mouse PRC and purified mouse renin was steepest at pH 8.5 and flat at pH 6.0. Mouse PRC was highly correlated with direct RIA measurements (r = 0.93). PRA before lisinopril was little influenced by pH, whereas the increase with lisinopril was greatest at pH 6.5. PRC before lisinopril was fourfold higher at pH 8.5 compared with that at pH 6.0. Lisinopril increased both PRC values but reversed the pH dependency. Prorenin was fourfold higher at pH 8.5 compared with that at pH 6.0 and decreased slightly with lisinopril. Renal renin concentration was higher at pH 6.0 than at pH 8.5. With lisinopril, renal renin concentration increased at both pH values. Mouse PRC was not changed by lisinopril. Ribonuclease protection assay showed both rat and mouse renin gene expression in the kidney, which increased with lisinopril. Thus TGR have circulating active rat and mouse renin and prorenin. The notion that TGR are a "low renin" model should be revised.

Citing Articles

Resetting of renal tissular renin-angiotensin and bradykinin-kallikrein systems after unilateral kidney denervation in rats.

Bohlender J, Nussberger J, Birkhauser F, Grouzmann E, Thalmann G, Imboden H Histochem Cell Biol. 2017; 147(5):585-593.

PMID: 28220244 DOI: 10.1007/s00418-017-1543-y.


Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.

Varcabova S, Huskova Z, Kramer H, Hwang S, Hammock B, Imig J Clin Exp Pharmacol Physiol. 2012; 40(4):273-81.

PMID: 23039246 PMC: 3769696. DOI: 10.1111/1440-1681.12018.


Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat.

Whaley-Connell A, Habibi J, Nistala R, Hayden M, Pulakat L, Sinak C Regul Pept. 2012; 176(1-3):36-44.

PMID: 22465166 PMC: 3348429. DOI: 10.1016/j.regpep.2012.03.002.


Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.

Whaley-Connell A, Nistala R, Habibi J, Hayden M, Schneider R, Johnson M Am J Physiol Renal Physiol. 2009; 298(3):F655-61.

PMID: 20007350 PMC: 2838585. DOI: 10.1152/ajprenal.00373.2009.


Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats.

Lindsey S, Cohen J, Brosnihan K, Gallagher P, Chappell M Endocrinology. 2009; 150(8):3753-8.

PMID: 19372194 PMC: 2717873. DOI: 10.1210/en.2008-1664.